Amgen Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Biologic Drugs for Amgen
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 1989-06-01 | See Plans and Pricing | |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 1989-06-01 | 5,441,868 | See Plans and Pricing |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 1989-06-01 | 5,547,933 | See Plans and Pricing |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 1989-06-01 | 5,618,698 | See Plans and Pricing |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 1989-06-01 | 5,756,349 | See Plans and Pricing |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
This search can help find similar names.